ARID1A and endometrial cancer: ARID1A (AT-rich interaction domain 1A), a subunit of the BAF complex, has been identified as one of the most frequently mutated tumor suppressors in a variety of cancers, with the highest mutation frequency in ovarian clear cell carcinoma (OCCC) [4] and endometrial cancer [5].